When billed and allowed amounts aren’t enough: HealthVerity proprietary market cost offering in taXonomy
A better way to measure healthcare costs in closed claims data This is the second post in our...
A better way to measure healthcare costs in closed claims data This is the second post in our...
How clinical data linkage closes evidence gaps in real-world data Clinical data linkage helps...
Artificial intelligence is moving quickly into healthcare research, but one question still comes...
One in nine Americans age 65 and older has Alzheimer’s disease (AD), a devastating illness that...
RWE and HEOR teams face increasing pressure to produce evidence that holds up beyond internal...
Healthcare marketing has reached an inflection point and for years, success was defined by reach:...
Capturing the true complexity of psoriasis in the real world Psoriasis is a common chronic...
Industry trends in ulcerative colitis research: a new path Ulcerative colitis is a chronic...
New research is challenging long-held assumptions about privacy-preserving record linkage (PPRL)....
Real-world evidence (RWE) studies often stall on the same friction points: defining the most...
In epidemiology, statistical power determines whether a study can accurately detect an effect of a given size with a specified probability, typically 80% or higher. When studies fall below that threshold, the consequences extend well beyond inconclus...